(5.3) Hypoglycemia: Concomitant use with insulin or an insulin secretagogue may increase the risk of hypoglycemia, including severe hypoglycemia
10.1331/JAPhA.2009.09078 131 NeumillerJ
FDA News Release: November 8 (2023) Accessed online at: Last accessed June 22, 2024 von Elm E, Altman DG, Egger M, Pocock SJ, Gtzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
For daily formulations, aligning injection time with your most challenging eating period makes intuitive and pharmacokinetic sense
Insoluble fiber in whole wheat and veggies keeps things moving in the gut
Less tyrosinase activity = less melanin = visibly lighter, more even skin over time